
Conference Coverage
Latest News

Trispecific Antibody IBI3003 Receives Fast Track Designation for Relapsed or Refractory Multiple Myeloma

Q&A: Guiding Breast Cancer Treatment With Genomic Risk Stratification

Q&A: A Growing Divide Between Federal Vaccine Policy and Clinical Practice

Growth Differentiation Factor-15: A Multifaceted Player in Prostate Cancer Biology and Therapeutic Targeting

Bipartisan Legislation Introduced to Control Drug Prices, ‘Corporate Greed’ Within Health Care

Shorts










Podcasts
Videos
Continuing Education
All News

The FDA declines to review Moderna’s mRNA flu vaccine filing over comparator choice, despite positive phase 3 results.

The updates allow for patients of reproductive age to complete pregnancy tests at home during or after treatment.

The phase 3 ADRIATIC trial demonstrates that consolidation durvalumab following concurrent chemoradiotherapy improves survival while maintaining health-related quality of life.

Vitamin B12 supports cognitive health, corrects deficiency in pills or shots, and helps pharmacists guide smart vitamin and supplement choices.

Learn how pharmacists cut GLP-1 costs, streamline prior authorizations, guide safe switches, and bust social media myths for lasting adherence.

Real-world FAERS data reveal venlafaxine’s known risks plus rare late-onset events and subgroup patterns, guiding long-term prescribing.

The most pronounced association was observed when individuals consumed 2 to 3 cups of caffeinated coffee per day.

FDA approval expands pembrolizumab (Keytruda) for PD‑L1+ platinum‑resistant ovarian cancer, pairing with paclitaxel ± bevacizumab to improve survival outcomes.

The Medications Optimizing Maternal Safety (MOMS) program offers vital support to pregnant patients through community pharmacies.

Intranasal ketamine may remain a potentially viable treatment method for acute pain.

RESTORE trial data show investigational elritercept improves myelofibrosis anemia and cytopenias, reduces transfusions, and guides pharmacists on monitoring with ruxolitinib.

Ann Marie Navar, MD, PhD, explains how enlicitide’s sustained LDL-C lowering, favorable tolerability, and structured dosing may improve adherence and expand oral add-on options for patients not at goal on statins.


Bangladesh reports fatal Nipah case linked to raw date palm sap; experts say spread stays limited as vaccines and rapid tests advance.

Although historically conceptualized as a childhood condition, it is now well established that ADHD frequently continues across the life span, with symptoms evolving rather than resolving.

DPYD Testing reshapes oncology dosing for 5‑FU/capecitabine to prevent toxicity and personalize chemotherapy.

The HHS secretary overstated preliminary research showing the benefits of a keto diet in patients with schizophrenia who remain adherent to medications.

Learn how workplace triggers, long flares, and new therapies reshape pharmacist-led care for chronic hand eczema.

Incremental, plant-based dietary changes can improve glycemic control, weight, and lipid outcomes while complementing cardiometabolic pharmacotherapy in routine pharmacy practice.

The platform offers uninsured patients discounted drug prices, though it is important to note that the platform does not sell drugs, and only a small number are currently available.

The scientific statement underscores obesity as a complex, socially driven condition and positions pharmacists as key partners in reducing stigma, improving access to care, and supporting equitable weight management.

Sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients with type 2 diabetes (T2D) was found to reduce the risk of chronic kidney disease (CKD) and key associated factors, like eGFR and albuminuria.

Pharmacist-owners occupy a unique position in health care. Unlike shareholder-driven corporate structures, pharmacist-led enterprises are uniquely positioned to balance financial health with professional obligation.






























